Mark A. Velleca, Director at G1 Therapeutics, Inc. (GTHX), sold 15,000 shares at $11.70 ($176K) on 2022-10-18, disclosed to the SEC on 2022-10-20.
Open-market sale of $176k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |
| GTHX | SELL | 2021-06-17 | $876K | — | Filing → |